Bcl-2 is an apoptosis inhibitor, but bax is an apoptosis inducer [35]; hence, the determination of bcl-2 and bax levels can be used as a crucial judge of the malignancy of gliomas. This evidence concerns the gene BCL2 and central nervous system cancer.